International safety notice

Safety Notice for the ADVIA Centaur products: Fluorescein Interference with ADVIA Centaur Systems TSH3 Ultra, Vitamin D and ADVIA Centaur BRAHMS Procalcitonin Assays, Siemens Healthcare

Germany / BfArM · DEU · May 6, 2014

Key facts

Title Safety Notice for the ADVIA Centaur products: Fluorescein Interference with ADVIA Centaur Systems TSH3 Ultra, Vitamin D and ADVIA Centaur BRAHMS Procalcitonin Assays, Siemens Healthcare
Regulator Germany / BfArM
Country DEU
Brand the ADVIA Centaur products: Fluorescein Interference with ADVIA Centaur Systems TSH3 Ultra, Vitamin D and ADVIA Centaur BRAHMS Procalcitonin Assays, Siemens Healthcare
Manufacturer Safety Notice for the ADVIA Centaur products: Fluorescein Interference with ADVIA Centaur Systems TSH3 Ultra, Vitamin D and ADVIA Centaur BRAHMS Procalcitonin Assays, Siemens Healthcare
Models 10282379, 10491994, 06491072, 10818132, 10631021, 10378883, 06491080, 10591, TSH3-UL, 10699201, 10699533, 10282378
Date May 6, 2014
Regulator page bfarm.de

At a glance

  • No Recall
  • No Field safety notice
  • 10–99 Matching device models in FDA data
  • 10–99 Matching catalog numbers in FDA data

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About International device safety notices

Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.

Source: National medical device regulators (as listed), compiled by Orca1

Browse all International device safety notices